Viewing Study NCT01516450


Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2025-12-25 @ 10:31 PM
Study NCT ID: NCT01516450
Status: COMPLETED
Last Update Posted: 2017-06-12
First Post: 2011-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Japanese phase1 Study of Belimumab (IV vs SC)
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module